Arca
Skip to content

Pharyngitis

Drug research and approvals for pharyngitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 17, 2026, 41 studies of pharyngitis are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 41
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 41 recruiting on ClinicalTrials.gov ↗

Drug Pipeline

19 approved, 11 in phase 3, 3 in phase 2; from ChEMBL's drug indications, furthest stage reached for this condition

Approved: Acetaminophen, Benzocaine, Telithromycin, Menthol, Amoxicillin, Ibuprofen, Chlorhexidine, Chlorpheniramine, Diphenhydramine, Cefaclor anhydrous, Cefuroxime axetil, Cefprozil anhydrous, (e)-, Cefdinir, Cefadroxil, Cefixime, Cefditoren pivoxil, Clarithromycin, Azithromycin, Hydrogen peroxide

Lidocaine
Phase 3 Sodium channel alpha subunit blocker
Ambroxol
Phase 3
Flurbiprofen
Phase 3 Cyclooxygenase inhibitor
Penicillin g
Phase 3 Bacterial penicillin-binding protein inhibitor
Ketamine
Phase 3 Glutamate [NMDA] receptor negative allosteric modulator
Celecoxib
Phase 3 Cyclooxygenase-2 inhibitor
Valdecoxib
Phase 3 Cyclooxygenase-2 inhibitor
Dexmedetomidine
Phase 3 Adrenergic receptor alpha-2 agonist
Aspirin
Phase 3 Cyclooxygenase inhibitor
Meloxicam
Phase 2 Cyclooxygenase-2 inhibitor
Naproxen
Phase 2 Cyclooxygenase inhibitor
Dexamethasone
Phase 2 Glucocorticoid receptor agonist

How Its Trials Ended

237 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 47 whose ending is known, 60% met their primary endpoint, 9% missed it and 32% stopped early.

  • Completed, result not reported11749%
  • Status unknown3816%
  • Ongoing3515%
  • Met its primary endpoint2812%
  • Stopped: other or unclear94%
  • Stopped: sponsor or business decision52%
  • Missed its primary endpoint42%
  • Stopped: enrollment or feasibility10%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.